Related references
Note: Only part of the references are listed.A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients
Holly LaDuca et al.
GENETICS IN MEDICINE (2020)
High risk of breast cancer in women with biallelic pathogenic variants in CHEK2
Irene Rainville et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients
Allison W. Kurian et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing
Hsiao-Mei Lu et al.
JAMA ONCOLOGY (2019)
Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history
Kari G. Chaffee et al.
GENETICS IN MEDICINE (2018)
Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer
Chunling Hu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer
Jan Hauke et al.
CANCER MEDICINE (2018)
Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death
Rong Na et al.
EUROPEAN UROLOGY (2017)
Rare germline variants in known melanoma susceptibility genes in familial melanoma
Alisa M. Goldstein et al.
HUMAN MOLECULAR GENETICS (2017)
Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma
Koji Shindo et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Clinical testing with a panel of 25 genes associated with increased cancer risk results in a significant increase in clinically significant findings across a broad range of cancer histories
Eric T. Rosenthal et al.
CANCER GENETICS (2017)
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer
Fergus J. Couch et al.
JAMA ONCOLOGY (2017)
Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer
Rachel Pearlman et al.
JAMA ONCOLOGY (2017)
Penetrance of ATM Gene Mutations in Breast Cancer: A Meta-Analysis of Different Measures of Risk
Monica Marabelli et al.
GENETIC EPIDEMIOLOGY (2016)
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
Melissa C. Southey et al.
JOURNAL OF MEDICAL GENETICS (2016)
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
C. C. Pritchard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Ataxia telangiectasia: a review
Cynthia Rothblum-Oviatt et al.
ORPHANET JOURNAL OF RARE DISEASES (2016)
Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome
Matthew B. Yurgelun et al.
GASTROENTEROLOGY (2015)
Loss-of-function variants in ATM confer risk of gastric cancer
Hannes Helgason et al.
NATURE GENETICS (2015)
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
J. Mateo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Prevalence of deleterious ATM germline mutations in gastric cancer patients
Dong-Sheng Huang et al.
ONCOTARGET (2015)
A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes
J. M. Eggington et al.
CLINICAL GENETICS (2014)
International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer
Marcia Irene Canto et al.
GUT (2013)
Rare variants in the ATM gene and risk of breast cancer
David E. Goldgar et al.
BREAST CANCER RESEARCH (2011)
The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo
Victoria J. Weston et al.
BLOOD (2010)
Rare, Evolutionarily Unlikely Missense Substitutions in ATM Confer Increased Risk of Breast Cancer
Sean V. Tavtigian et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2009)
Risk of cancer by ATM missense mutations in the general population
Sarah Louise Dombernowsky et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Characterization of the breast cancer associated ATM 7271T>G (V2424G) mutation by gene expression profiling
Nic Waddell et al.
GENES CHROMOSOMES & CANCER (2006)
Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T > G and c.1066-6T > G (IVS10-6T > G) from the breast cancer family registry
J. L. Bernstein et al.
HUMAN MUTATION (2006)
ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles
Anthony Renwick et al.
NATURE GENETICS (2006)
Share Paper
